Higher levels of 2-AG, due to MAGL inhibition by JZL184 have also been implicated in synaptic and cognitive improvements in a model of Alzheimer's disease (Zhang et al., 2014). This evidence concerns the gene MGLL and early-onset autosomal dominant Alzheimer disease.